On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis. Yip TC, Chan HL, Tse YK, Lam KL, Lui GC, Wong VW, et al. University of Wisconsin School of Medicine and Public Health. Model for End-stage Liver Disease (MELD) score and liver transplant: benefits and concerns. doi:10.2147/CEG.S160537Īiello FI, Bajo M, Marti F, Gadano A, Musso CG. Liver function tests in identifying patients with liver disease. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values. Johnson SA, Vazquez SR, Fleming R, Lanspa MJ. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study. Equation MELD Score (Original, Pre-2016) MELD Na (UNOS/OPTN) MELD 3.0 Result: Please fill out required fields. The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. Zaydfudim VM, Turrentine FE, Smolkin ME, et al. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. The updated table lists the MMaT for each liver transplant hospital effective as of that date, as well as the details of the MMaT calculation. Important predictor of mortality in patients with end-stage liver disease. Effective March 30, the median MELD at transplant (MMaT) for liver candidates with exception scores was updated by the Organ Procurement and Transplantation Network (OPTN). Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |